The work considers the problem of obtaining nanocolloid radiopharmaceuticals (RPs) and studying their functional suitability for diagnosing sentinel lymph nodes (SLN) in cancer patients. Two principal approaches to the formation of technetium-99m-labeled particles based on inorganic and organic matrices were considered when carrying out research to develop methods for the production of nanocolloid RPs. The composition of the reagents and the conditions for obtaining nanocolloid radiopharmaceuticals were determined. The functional suitability of new RPs for scintigraphic diagnostics of sentinel lymph nodes has been studied.
24 September 2014 in Journal of Radioanalytical and Nuclear Chemistry
The paper presents the procedure for planning an experiment to create standard sets of reagents for a technetium-99m generator based on glucose derivatives. All stages are presented from researching the required quantities of a substance, a reducing agent, a stabilizer and auxiliary components to developing lyophilized kits and conducting quality control. The radiochemical purity of radiopharmaceuticals prepared on the basis of the developed kits ranged from 90.0 to 99.0%. We also showed the functional suitability of the developed preparations on C57B1/6j mice with an implanted malignant tumor - Lewis lung carcinoma.
The authors have researched the possibility of radioactive 99mTc labeling of the surface of carbon-coated nano-sized ferrum Fe@C particles as well as Fe@C (IDA) particles modified by aryldiazonium tosilates. Non-modified particles proved to absorb up to 11.2 % of 99mТс injected amount. The value of atomic absorption does not exceed 0.736∙10-9 g-at 99mТс per 1 g of Fe@C. No physical absorption is observed on modified particles of Fe@C (IDA). In chemical interaction of the particles with 99mTc in the presence of a reducing agent, Sn (II), the yield of the labeled product increases 1.5 times and reaches 21.3% of the total induced radioactivity of the radionuclide.
3 December 2015 in Indian Journal of Science and Technology
Background/Objectives: The regularities of adsorption 99mТс on activated nanoscale powder gamma-oxide Al2O3 were investigated. Methods/Statistical Analysis: As object of examination nanopowder low-temperature (cubic) modification of gamma-oxide Al2O3 is used. The area of specific surface of aluminum oxide was 320 m2/g. According to submicroscopy, the particles had the improper shape and a rough surface. For obtaining of an initial drug 99mTc (eluate) in the form of a sodium pertechnetate solution, 99mTc was produced with the chromatographic generator of “99mTc-GT-TOM” productions of PTI TPU. The stability of the complex was determined by measuring the RCP at room temperature (24°C) at different time points (0, 1, 2, 4 h) after preparation. Findings: It is shown that sorption capacity of aluminum oxide essentially depends on its acid treatment. Experimental research of process of adsorption 99mTc in the presence of reducing agent of tin (II) is made. It’s necessary and sufficient amount providing full “reducibleness” 99mТс in a reaction mixture is spotted. For yield rising nanocolloids with particle size less than 100 nanometers and risings of radiochemical purity of drugs additives of sodium pyrophosphate, ascorbic acid and gelatine were used. Pre-award medicobiological tests of nanocolloids preparate 99mTs-Al2O3 on the observational animals to define the functional operability for scintigraphic visualisation of lymph nodes are conducted. Applications/Improvements: Is of practical importance for carrying out of diagnostic researches in cardiology, oncology and other fields of medicine.
The paper considers properties of nano-sized particles and methods of well-known technetium-99m-based nanocolloid materials preparation. We present a production technique of Al2O3-based nanocolloid labeled with technetium-99m developed at the Institute of Physics and Technology of TPU. We also give the results of preliminary medico-biological testing of 99mТс (IV)-Al2O3 pharmaceutical on animals for determining its operational suitability for scintigraphic visualization of lymphatic nodes.